Overview of Dr. Hershman
Dr. Dawn Hershman is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 23 years. Dr. Hershman accepts several types of health insurance, listed below. She is one of 64 doctors at New York-Presbyterian Hospital and one of 25 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Hematology. She has more than 100 publications and over 500 citings.
Office
161 Fort Washington Ave
New York, NY 10032
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1998 - 2001
- Columbia University School of Public HealthMSc, Biostatistics, 2001
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1994 - 1998
- Albert Einstein College of MedicineClass of 1994
- University of California, Los AngelesB.A., Psychology, 1987
Certifications & Licensure
- FL State Medical License 2022 - Present
- NJ State Medical License 2022 - 2025
- NY State Medical License 1995 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2011-2014
- Breast Cancer Medical Advancement Award AVON, 2010
- Leadership Development Program Awardee ASCO, 2009
- Join now to see all
Clinical Trials
- Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer Start of enrollment: 2001 Dec 01
- S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone Start of enrollment: 2006 May 01
- Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial Start of enrollment: 2006 Apr 24
- Join now to see all
Publications & Presentations
PubMed
- 189 citationsAssociation between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant pac...Dawn L. Hershman, Louis H. Weimer, Antai Wang, Grace Kranwinkel, Lois Brafman
Breast Cancer Research and Treatment. 2011-02-01 - 17 citationsOveruse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014Jason D. Wright, Ling Chen, Ana I. Tergas, Alexander Melamed, Caryn M. St. Clair
JAMA Network Open. 2021-04-01 - 375 citationsRobotically assisted vs laparoscopic hysterectomy among women with benign gynecologic diseaseJason D. Wright, Cande V. Ananth, Sharyn N. Lewin, William M. Burke, Yu Shiang Lu
JAMA. 2013-02-20
Journal Articles
- Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women with Early-Stage Breast CancerA Randomized Clin...Dawn L Hershman, Jillian L Capodice, William H Kreisle, Michael J Fisch, Marianne K Melnik, Alice T Kengla, Carla W Jorgensen, Heather Greenlee, JAMA
- Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology StatementLigibel JA, Alfano CM, Hershman DL, Ballard RM, Bruinooge SS, Courneya KS, Daniels EC, Demark-Wahnefried W, Frank ES, Goodwin PJ, Irwin ML, Levit LA, McCaskill-Stevens..., J Clin Oncol, 1/31/2015
- Population-based assessment of determining predictors for quality of prostate cancer surveillanceChamie K, Williams SB, Hershman DL, Wright JD, Nguyen PL, Hu JC, Cancer, 1/26/2015
- Join now to see all
Books/Book Chapters
Lectures
- Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials.2019 ASCO Annual Meeting - 6/1/2019
- Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105.2019 ASCO Annual Meeting - 6/1/2019
- Long Term Consequences of Intermittent and Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer1/1/2015
- Join now to see all
Authored Content
- Characteristics Associated with Prolonged Length of Stay After Hysterectomy for Benign Gynecologic ConditionsMay 2018
Press Mentions
- Study Highlights Long-Term Risks of Prostate Cancer TreatmentNovember 6th, 2024
- Risk Model Identifies Advanced Cancer Trial Patients at Highest Risk for Acute Care UseSeptember 24th, 2024
- New Model Identifies Cancer Patients at High Risk for ER Visits During Clinical TrialsSeptember 22nd, 2024
- Join now to see all
Grant Support
- Acupuncture For Aromatase Inhibitor-Related Arthralgias In Breast Cancer PatientsNational Center For Complementary &Alternative Medicine2011–2012
- Determinants And Risks Of Use And Overuse Of Expensive Oncology DrugsNational Cancer Institute2008–2011
- Osteoporosis Prevention In Early Stage Breast CancerNational Cancer Institute2002–2006
- Pilot--Ethnic Neutropenia In African-Americans And Afro-CaribbeansNational Cancer Institute2003
- Pilot--Ethnic Neutropenia In African Americans And Afro-National Cancer Institute2003
Professional Memberships
- Member
Insurance Accepted
- Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPOGHI PPO
Great West PPO
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: